Pathophysiology of polymorphonuclear leukocyte in arterial hypertension

Clinical Hemorheology and Microcirculation

Volumn 41, Issue 3, 2009, Pages 209-218

  Hopps, Eugenia ^a   Presti, Rosalia Lo ^a   Caimi, Gregorio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Adhesion molecules; Hypertension; Oxidative stress; Polymorphonuclear leukocytes

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; BENIDIPINE; BETA2 INTEGRIN; CALCIUM CHANNEL BLOCKING AGENT; CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROGEN PEROXIDE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LACIDIPINE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; VASCULAR CELL ADHESION MOLECULE 1; CD18 ANTIGEN;

ADIPOSE TISSUE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CARDIOVASCULAR RISK; CELL INTERACTION; CYTOSOL; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HYPERTENSION; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LEUKOCYTOSIS; LIPID PEROXIDATION; MITOCHONDRION; NEUTROPHIL; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; REVIEW; T LYMPHOCYTE SUBPOPULATION; VASCULAR ENDOTHELIUM; BIOSYNTHESIS; LEUKOCYTE ROLLING; METABOLISM; PATHOLOGY;

ANTIGENS, CD18; HUMANS; HYPERTENSION; LEUKOCYTE COUNT; LEUKOCYTE ROLLING; LIPID PEROXIDATION; NADPH OXIDASE; NEUTROPHILS; SUPEROXIDE DISMUTASE;

EID: 67649396587     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2009-1173     Document Type: Review

References (80)

1. A. Amaro, F. Gude, R. Gonzalez-Juanatery, C. Iglesias, F. Fernandez-Vasquez, J. Garcia-Acuna and M. Gil, Plasma leukocyte elastase concentration in angiographically diagnosed coronary artery disease, European Heart Journal 16 (1995), 615-622.
2. M.C. Armas-Padilla, M.J. Armas-Hernández, B. Sosa-Canache, R. Cammarata, B. Pacheco, J. Guerrero, A.R. Carvajal, R. Hernández- Hernández, Z.H. Israili and M. Valasco, Nitric oxide and malondialdehyde in human hypertension, American Journal of Therapy 14 (2007), 172-176.
3. H. Arndt, C.W. Smith and D.N. Granger, Leukocyte-endothelial cell adhesion in spontaneously hypertensive and normotensive rats, Hypertension 21 (1993), 667-673.
4. R.F. Bing, A.M. Heagerty, J.A. Jackson, H. Thurston and J.D. Swales, Leukocyte ionized calcium and sodium content and blood pressure in humans, Hypertension 8 (1986), 483-488.
5. A.D. Blann, W. Tse, S.J.R. Maxwell and M.A. Waite, Increased levels of the soluble adhesion molecule E-selectin in essential hypertension, Journal of Hypertension 12 (1994), 925-928.
6. M. Boschmann, S. Engeli, F. Adams, K. Gorzelniak, G. Franke, S. Klaua, U. Kreuzberg, S. Luedtke, R. Kettritz, A.M. Sharma, F.C. Luft and J. Jordan, Adipose tissue metabolism and CD11b expression on monocytes in obese hypertensives, Hypertension 46 (2005), 130-136.
7. M. Buemi, A. Allegra, C. Aloisi, F. Corica, A. Alonci, A. Ruello, G. Montalto and N. Frisina, Cold pressor test raises serum concentrations of ICAM-1, VCAM-1 and E-selectin in normotensive and hypertensive patients, Hypertension 30 (1997), 845-847.
8. G. Caimi, Erythrocyte, platelet and polymorphonucelar leukocyte membrane dynamic properties in essential hypertension, Clinical Hemorheology and Microcirculation 17 (1997), 199-208.
9. G. Caimi, Polymorphonuclear leukocyte integrin profile in essential hypertension, American Journal of Hypertension 13 (2000), 1501-1502.
10. 2+ content in different clinical conditions, Clinical Hemorheology and Microcirculation 17 (1997), 217-223.
11. G. Caimi, A. Contorno, A. Serra, A. Catania, R. Lo Presti, A. Sarno and G. Cerasola, Red cell metabolic parameters and rheological determinants in essential hypertension, Clinical Hemorheology 13 (1993), 35-44.
12. G. Caimi, R. Lo Presti, B. Canino, M. Montana and G. Cerasola, Essential hypertension: polymorphonuclear leukocyte membrane fluidity at baseline and after chemotactic activation, American Journal of Hypertension 12 (1999), 947-948.
13. 2+ content at baseline and after activation, Clinical Hemorheology and Microcirculation 19 (1998), 281-289.
14. 2+ content after activation in essential hypertension, Hypertension 36 (2000), 813-817.
15. C. Calvo, R.C. Hermida, V. Lahera, D.E. Ayala and J.E. Lopez, Leukocyte count and globular sedimentation velocity, costeffective markers of inflammation, are increased in metabolic syndrome, American Journal of Hypertension 18 (2005), A194.
16. A. Chabanel and S. Chen, Blood viscosity as a factor in human hypertension, in: Hypertension: Pathophysiology, Diagnosis and Management, J.H. Laragh and B.M. Brenner, eds, Raven Press, Ltd., New York, 1990, pp. 329-337.
17. M. Chatterjee, R. Saluja, S. Kanneganti, S. Chinta and M. Dikshit, Biochemical and molecular evaluation of neutrophil NOS in spontaneously hypertensive rats, Cellular and Molecular Biology 15 (2007), 84-93.
18. D. Cooper, K.Y. Stokes, A. Tailor and D.N. Granger, Oxidative stress promotes blood cell-endothelial cell interactions in the microcirculation, Cardiovascular Toxicology 2 (2002), 165-180.
19. C.A. De Souza, D.R. Dengel, R.F. Macko, K. Cox and D.R. Seals, Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension, American Journal of Hypertension 10 (1997), 1335-1341.
20. M.S.V. Elkind, R.R. Sciacca, B. Boden-Albala, M.L.C. Tondella, D.R. Feikin, B.S. Fields, R.L. Sacco, M.R. Di Tullio and S. Homma, Leukocyte count is associated with reduced endothelial reactivity, Atherosclerosis 181 (2005), 329-338.
21. N.J. Fardon, R. Wilkinson and T.H. Thomas, Rapid fusion of granules with nwutrophil cell membranes in hypertensive patients may increase vascular damage, American Journal of Hypertension 14 (2001), 927-933.
22. G.D. Friedman, J.Y. Selby and C.P. Quesenberry Jr., The leukocyte count: a predictor of hypertension, Journal of Clinical Epidemiology 43 (1990), 907-911.
23. R.F. Gillum and M.E. Mussolino, White blood cell count and hypertension incidence. The NHANES I Epidemiologic Follow-up Study, Journal of Clinical Epidemiology 47 (1994), 911-919.
24. B. Glowinska, M. Urban, J. Peczynska and B. Floris, Soluble adhesion molecules (sICAM-1, sVCA-1) and selectins (sE-selectin, sP-selectin, sL-selectin) levels in children and adolescents with obesity, hypertension and diabetes, Metabolism 54 (2005), 1020-1026.
25. M. Grafe, W. Auch-Schwelk, A. Zakrewicz, V. Regitz-Zagrosek, P. Bartsch, K. Graf, M. Loebe, P. Gaethgens and E. Fleck, Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin, Circulation Research 81 (1997), 801-811.
26. 2 production and elastase release in human neutrophils, Pharmacology & Toxicology 79 (1996), 312-317.
27. M.H. Jackson, A. Collier, J.J. Nicoll, A.L. Muir, J. Dawes, B.F. Clarke and D. Bell, Neutrophil count and activation in vascular disease, Scottish Medical Journal 37 (1992), 41-43.
28. K.H. Jung, K. Chu, S.T. Lee, S.J. Kim, E.C. Song, E.H. Kim, D.K. Park, D.I. Sinn, J.M. Kim, M. Kim and J.K. Roh, Blockade of AT1 receptor reduces apoptosis, inflammation and oxidative stress in normotensive rats with intracerebral hemorrhage, Journal of Pharmacology and Experimental Therapeutics 322 (2007), 1051-1058.
29. F. Khalfi, B. Gressier, C. Brunet, T. Dine, M. Luyckx, M. Cazin and J.C. Cazin, Effects of calcium antagonist diltiazem on leukocyte elastase and on reactive oxygen species production in human neutrophils, Pharmacological Research 33 (1996), 117-122.
30. F. Khalfi, B. Gressier, T. Dine, C. Brunet, M. Luyckx, L. Ballester, M. Cazin and J.C. Cazin, Verapamil inhibits elastase release and superoxide anion production in human neutrophils, Pharmaceutical Bulletin 21 (1998), 109-112.
31. C.H. Kim and N.D. Vaziri, Hypertension promotes integrin expression and reactive oxygen species generation by circulating leukocyte, Kidney International 67 (2005), 1462-1470.
32. 2 production in circulating and splenic leukocytes of obese rats, Obesity 15 (2007), 2209-2216.
33. S. Komatsu, J. Panes, J.M. Russel, D.C. Anderson, V.R. Muzykantov, M. Miysaka and D.N. Granger, Effects of chronic arterial hypertension on constitutive and induced intracellular adhesion molecule-1 expression in vivo, Hypertension 29 (1997), 683-689.
34. S. Kopprash, J. Graessler, R. Seibit, H.J. Naumann, K. Scheuch, R. Henbge and U. Schwanebeck, Leukocyte responsiveness to substances that activate the respiratory burst is not altered in borderline and essential hypertension, Journal of Human Hypertension 10 (1996), 69-76.
35. F. Kouoh, B. Gressier, T. Dine, M. Luyckx, C. Brunet, L. Ballester and J.C. Cazin, Antioxidant effects and anti-elastase activity of the calcium antagonist nicardipine on activated human and rabbit neutrophils-a potential antiatherosclerotic property of calcium antagonists?, Cardiovascular Drugs and Therapy 16 (2002), 515-520.
36. F. Kouoh, B. Gressier, T. Dine, M. Luyckx, C. Brunet, L. Ballester and J.C. Cazin, In vitro and ex vivo antioxidant activities of labetalol on rabbit neutrophil respiratory burst, Advances in Therapy 21 (2004), 178-185.
37. B. Kristal, R. Shurtz-Swirski, J. Chezar, J. Manaster, R. Levy, G. Shapiro, I. Weissman, S.M. Shasha and S. Sela, Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension, American Journal of Hypertension 11 (1998), 921-928.
38. A.J. Lee, The role of rheological and haemostatic factors in hypertension, Journal of Human Hypertension 11 (1997), 767-776.
39. P.D. Lew, L. Favre, F.A. Waldvogel and M.B. Vallotton, Cytosolic free calcium and intracellular calcium stores in neutrophils from hypertensive subjects, Clinical Science 69 (1985), 227-230.
40. 2+ content at baseline and after activation in essential hypertension, Trace Elements and Electrolytes 22 (2005), 207-210.
41. A. Madej, B. Okopieñ, J. Kowalski, M. Haberka and Z.S. Herman, Plasma concentrations of adhesion molecules and chemokines in patients with essential hypertension, Pharmacological Reports 57 (2005), 878-881.
42. K. Maeda, K. Yasunari, E.F. Sato, J. Yoshikawa and M. Inoue, Activation of protein kinase C and nicotinamide adenine dinucleotide phosphate oxidase in leukocytes of spontaneously hypertensive rats, Hypertension Research 26 (2003), 999-1006.
43. K.L. Margolis, J.E. Manson, P. Greenland, R.J. Rodabough, P.F. Bray, M. Safford, R.H. Grimm Jr., B.V. Howard, A.R. Assaf and R. Prentice, Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study, Archives of Internal Medicine 165 (2005), 500-508.
44. M. Matsubara, O. Akizuki, J. Ikeda, K. Saeki, K. Yao and K. Sasaki, Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats, European Journal of Pharmacology 580 (2008), 201-213.
45. R. Mazor, B. Kristal, M. Mazor, C. Yagil, Y. Yagil and S. Sela, A key role for primed polymorphonuclear leukocyte NADPH oxidase in the development of hypertension, American Journal of Hypertension 18 (2005), A184.
46. R. Mazor, R. Shurtz-Swirski, S. Sela, G. Shapiro and B. Kristal, Polymorphonuclear leukocyte priming and counts are in correlation with blood pressure parameters, Harefuah 145 (2006), 900-903.
47. M.A. Miller, S.M. Kerry, D.G. Cook and F.P. Cappuccio, Cellular adhesion molecules and blood pressure: interaction with sex in a multi-etnic population, Journal of Hypertension 22 (2004), 705-711.
48. A. Mugge and J.A.G. Lopez, Do leukocytes have a role in hypertension?, Hypertension 17 (1991), 331-333.
49. L. Nabha, J.C. Garbern, C.L. Buller and J.R. Charpie, Vascular oxidative stress precedes high blood pressure in spontaneously hypertensive rats, Clinical and Experimental Hypertension 27 (2005), 71-82.
50. S. Nomura, S. Kanazawa and S. Fukuhara, Effects of efonedipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus, Journal of Human Hypertension 16 (2002), 539-547.
51. J.K. Park, A. Fiebeler, D.N. Muller, E.M.A. Mervaala, R. Dechend, F. Abou-Rebyeh, F.C. Luft and H. Haller, Lacidipine inhibits adhesion molecule and oxidatse expression independent of blood pressure reduction in Angiotensin-induced vascular injury, Hypertension 39 (2002), 685-689.
52. L. Pastore, A. Tessitore, S. Martinotti, E. Toniato, E. Alesse, M.C. Bravi, G. Ferri, A. Desideri, A. Gulino and A. Santucci, Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo, Circulation 100 (1990), 1646-1652.
53. F. Portaluppi, B. Boari and R. Manfredini, Oxidative stress in essential hypertension, Current Pharmaceutical Design 10 (2004), 1695-1698.
54. I. Rahman and N. Nath, Glutathione and its redox system, superoxide anion and superoxide dismutases of polymorphonuclear leukocytes in essential hypertension, The Indian Journal of Medical Research 88 (1998), 64-70.
55. S. Riou, B. Mees, B. Esposito, R. Merval, J. Vilar, D. Stengel, E. Ninio, R. van Haperen, R. de Crom, A. Tedgui and S. Lehoux, High pressure promotes monocyte adhesion to the vascular wall, Circulation Research 100 (2007), 1226.
56. B. Rodriguez-Iturbe, N.D. Vaziri, J. Herrera-Acosta and R.J. Johnson, Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all, American Journal of Physiology. Renal Physiology 286 (2004), F606-616.
57. S. Sagar, I.J. Kallo, N. Kaul, N.K. Ganguly and B.K. Sharma, Oxygen free radicals in essential hypertension, Molecular and Cellular Biochemistry 111 (1992), 103-108.
58. H. Sanada, S. Midorikawa, J. Yatabe, M. Sasaki Yatabe, T. Katoh, T. Baba, S. Hashimoto and T. Watanabe, Elevation of serum soluble E-, P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker, Hypertension Research 28 (2005), 871-888.
59. B. Sandhagen, G. Frithz, U. Waern and G. Ronquist, Increased whole blood viscosity combined with decreased erythrocyte fluidity in untreated patients with essential hypertension, Journal of Internal Medicine 228 (1990), 623-626.
60. G. Schillaci, M. Pirro, G. Pucci, T. Ronti, G. Vaudo, M.R. Mannarino, C. Porcellati and E. Mannarino, Prognostic value of elevated white blood cell count in hypertension, American Journal of Hypertension 20 (2007), 364-369.
61. G.W. Schmid-Schonbein, D. Seiffge, F.A. DeLano, K. Shen and B.W. Zweifach, Leukocyte counts and activation in spontaneously hypertensive and normotensive rats, Hypertension 17 (1991), 323-330.
62. R. Seifert, G. Hilgenstock, M. Fassender and A. Distler, Regulation of the superoxide-forming NADPH oxidase of human neutrophils is not altered in essential hypertension, Journal of Hypertension 9 (1991), 147-153.
63. S. Sela, R. Mazor, M. Amsalam, C. Yagil, Y. Yagil and B. Kristal, Primed polymorphonuclear leukocytes, oxidative stress, and inflammation antecede hypertension in the Sabra rat, Hypertension 44 (2004), 764.
64. S. Sela, R. Shurtz-Swirski, R. Farah, R. Levy, G. Shapiro, J. Chezar, S.M. Shasha and B. Kristal, A link between polymorphonuclear leukocyte intracellular calcium, plasma insulin and essential hypertension, American Journal of Hypertension 15 (2002), 291-295.
65. K. Shen, K.L. Sung, D.E. Whittemore, F.A. DeLano, B.W. Zweifach and G.W. Schmid-Schonbein, Properties of circulating leukocytes in spontaneously hypertensive rats, Biochemistry and Cell Biology 73 (1995), 491-500.
66. E.V. Shliakhto, O.M. Moiseeva, E.A. Liasnikova, S.V. Villeval'de and I.V. Emel'ianov, Rheological properties of blood and endothelial function in patients with hypertensive disease, Kardiologiia 44 (2004), 20-23.
67. E. Shima, M. Katsube, T. Kato, M. Kitagawa, F. Hato, M. Hino, T. Takahashi, H. Fujita and S. Kitagawa, Calcium channel blockers suppress cytokine-induced activation of human neutrophils, American Journal of Hypertension 21 (2008), 78-84.
68. A.C. Shore, G.W. Beynon, J.C. Jones, N.D. Markandu, G.A. Sagnella and G.A. MacGregor, Mononuclear leukocyte intracellular free calcium- Does it correlate with blood pressure?, Journal of Hypertension 3 (1985), 183-187.
69. C.G.C. Spencer, D.C. Felmeden, A.D. Blann and G.Y.H. Lip, Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian cardiac outcomes trial, Journal of Internal Medicine 261 (2007), 82-90.
70. M. Suematsu, H. Suzuki, F.A. DeLano and G.W. Schmid-Schonbein, The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis, Microcirculation 9 (2002), 259-276.
71. M. Suematsu, H. Suzuki, T. Tamatani, Y. Iigou, F.A. DeLano, M. Miysaka, M.J. Forrest, R. Kannagi, B.J. Zweifach, Y. Ishimura and G.W. Schmid-Schonbein, Impairment of selectin-mediated leukocyte adhesion to venular endothelium in spontaneously hypertensive rats, Journal of Clinical Investigation 96 (1995), 2009-2016.
72. H. Suzuki, B.J. Zweifach, M.J. Forrest and G.W. Schmid-Schonbein, Modification of leukocyte adhesion in spontaneously hypertensive rats by adrenal corticosteroids, Journal of Leukocyte Biology 57 (1995), 20-27.
73. M. Tucci, C. Quatraro, M.A. Frassanito and F. Silvestris, Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia, Journal of Hypertension 24 (2006), 1307-1318.
74. M.C. Verhaar, J.J. Beutler, C.A. Gaillard, H.A. Koomans, R. Fijnheer and T.J. Rabelink, Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin, Journal of Hypertension 16 (1998), 45-50.
75. Y.S. Wallace, C.M. McEniery, Z. Dakham, P. Pusalkar, K. Maki-Petaja, M.J. Ashby, J.R. Cokcroft and I.B. Wilkinson, Matrix metalloproteinase-9 (MMP-9), and serum elastase activity are associated with systolic hypertension and arterial stiffness, Arteriosclerosis, Thrombosis and Vascular Biology 25 (2005), 372-378.
76. N. Ward and K.D. Croft, Hypertension and oxidative stress, Clinical and Experimental Pharmacology and Physiology 33 (2006), 872-876.
77. H.Y. Yang, P.F. Kao, T.H. Chen, B. Tomlinson, W.C. Ko and P. Chan, Effects of the angiotensin II type 1 receptor antagonist valsartan on the expression of superoxide dismutase in hypertensive patients, Journal of Clinical Pharmacology 47 (2007), 397-403.
78. K. Yasunari, K. Maeda, M. Nakamura, T. Watanabe and J. Yoshikawa, Benidipine, a long-acting calcium channel blocker, inhibits oxidative stress in polymorphonuclear cells in patients with essential hypertension, Hypertension Research 28 (2005), 107-112.
79. K. Yasunari, K. Maeda, M. Nakamura, T. Watanabe, J. Yoshikawa and A. Asada, Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension, American Journal of Medicine 116 (2004), 460-465.
80. K. Yasunari, K. Maeda, M. Nakamura and J. Yoshikawa, Oxidative stress in leukocyte is a possible link between blood pressure, blood glucose and C-reactive protein, Hypertension 39 (2002), 777-780.